3rd Quarter - Report
OGR for TAKEDA PHARMACEUTICALS AMERICA INC
Firm
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the implementation of the Patient Protection and Affordable Care Act (Public Law No: 111-148), the pharmaceutical industry, diabetes care, obesity and mental health. H.R.2404/S.1509, Treat and Reduce Obesity Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| CHRIS GIBLIN | — |
| MOSES MERCADO | — |
| KARISSA WILLHITE | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| CHRIS GIBLIN | — |
| MOSES MERCADO | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.